Class not certified for abstract (“what if?”) harm respecting increased risk of cancer diagnosis: Palmer v. Teva Canada Ltd., 2022 ONSC 4690 | Alexander Holburn Beaudin + Lang LLP
Teva Canada Charts a New Prescription for Care | Business Wire
Teva Canada Completes Sale of Mirabel Facility to Halo Pharmaceutical | Technology Networks
Teva Canada launches new Autoinjector for Ajovy to prevent migraine in adults | Drug Store News
Acetaminophen recall: Incorrect dosage on label could lead to overdose, Health Canada says | CTV News
Teva Canada Announces Product Availability of AJOVY™ | Nasdaq
Teva Pharmaceutical Industries Ltd. - Test, test, and test again. Lisa Cameron and the Quality team at Teva Canada have their eyes on every angle of product quality to ensure our medicines
Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire
Teva Pharmaceuticals and State Responsible for Opioid Epidemic in NY, Jury Finds - Top Class Actions
Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget
U.S. accuses Israel's Teva of fixing drug prices
BASANT SINGH YADAV - Pilot Researcher-I - Teva Active Pharmaceutical Ingredients | LinkedIn
Teva Pharmaceutical Industries Ltd. - On Thursday May 12, Doug Sommerville General Manager Teva Canada, John Jacobs GM for Teva Canada Innovation, Ben Gray VP, General Counsel, Bennett Lee and Houri Ohan
Teva follows AbbVie to leave top pharma industry group (NYSE:TEVA) | Seeking Alpha
Teva Canada: Fashionable Active Sandals, River Shoes, Boots, & More | Teva® Canada